News Release

10/27/2016
Information
Shanghai Genomics Announces A Collaboration With TOKO on Healthcare Products
10/19/2016
Information
Notice of Ranking 5th in the 14th Deloitte Touche Tohmatsu LLC Japan Technology Fast50, A Ranking Program of Fastest-Growing Technology Companies
09/21/2016
Information
The article regarding Pirfenidone has been published on Nature.com Scientific Reports
09/09/2016
Information
Dr. Ying Luo, President and CEO of GNI Group Ltd., has been selected as a finalist for Asia Business Leaders Awards 2016
09/01/2016
Information
the 5th China Interstitial Lung Disease Conference
08/18/2016
Information
Shift to Direct Marketing Model for Etuary® Sales by Beijing Continent Pharmaceutical Co., Ltd.
06/24/2016
Information
IriSys Opens Business Development Office in Shanghai
06/02/2016
Information
GNI Group Increases Equity Investment in Beijing Continent Pharmaceuticals Co., Ltd.
01/18/2016
Information
New Year Greetings
12/08/2015
Release
57th Annual General Meeting of the American Society of Hematology Presentation of clinical trial results from China on tamibarotene as a treatment for acute promyelocytic leukemia
07/06/2015
Information
Macquarie Securities report on GNI was posted on Bloomberg
04/27/2015
Information
Initiation of Postmarketing Surveillance Studies of Etuary
03/06/2015
Event Calendar
Notice of email server maintenance
02/27/2015
Information
Announcement of the 14th Annual General Shareholder Meeting
01/30/2015
Release
Notice of Completion of Investment inIriSys, LLC